Finland· FI-REL-REL25363
Byetta
A exenatide product containing exenatide, registered in Finland by AstraZeneca AB. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Exenatide is registered in 10 of 19 countries.
Countries holding a registration under ATC A10BJ01 (exenatide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Exenatide · ATC A10BJ01
10 / 19 countries
- Belgiumprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of exenatide costs, country by country.
Normalised to the WHO defined daily dose (15 mcg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Exenatide · price per daily dose (15 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$0.26
The record
At a glance
Fimea (Finland)- Active substance
- Exenatide
- Manufacturer
- AstraZeneca AB
- Country
- Finland (FI)
- ATC code
- A10BJ01
- ATC class
- Exenatide
- Defined daily dose
- 15 mcg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
404 interactions on record for exenatide.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Exenatide · interactions on record
404 records
- 3 severe
- 359 moderate
- 42 minor
Most severe, free to view
- SucralfateA02BX02moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- MannitolA06AD16moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Exenatide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBydureon 2mg powder and solvent for prolonged-release suspension for injection pre-filled pensAstraZeneca UK Ltd
- United StatesByettaAstraZeneca Pharmaceuticals LP
- BelgiumBydureon 2 mgAstraZeneca
- SpainBYDUREON 2 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADAAstrazeneca Ab
- IrelandBydureon 2 mg powder and solvent for prolonged-release suspension for injectionAstraZeneca AB
- FranceBYDUREON 2 mg, poudre et solvant pour suspension injectable à libération prolongée en stylo prérempliASTRAZENECA AB
- ItalyBYDUREON*4 penne preriempite Bcise SC 2 mg 0,85 ml rilascio prolungatoASTRAZENECA AB
- NorwayBydureonAstraZeneca
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d7600f03-5168-4328-8858-ada4e60f87ad GET /v1/drugs/d7600f03-5168-4328-8858-ada4e60f87ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "15",
"form": "injektioneste, liuos, esitäytetty kynä",
"route": "Ihon alle",
"ddd_unit": "mcg",
"strength": "10 mikrog",
"atc_label": "eksenatidi",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/06/362/003-004",
"fimea_rel_id": "REL25363",
"authorised_at": "2006-11-20"
}See everything about exenatide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.